NovoCure
NVCR
NVCR
240 hedge funds and large institutions have $4.99B invested in NovoCure in 2019 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 74 increasing their positions, 83 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.93% less ownership
Funds ownership: 68.93% → 68% (-0.93%)
11% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 83
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
240
Holding in Top 10
4
Calls
$93M
Puts
$45M
Top Buyers
| 1 | +$120M | |
| 2 | +$58.3M | |
| 3 | +$49.8M | |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$42.8M |
| 5 |
BlackRock
New York
|
+$27.5M |
Top Sellers
| 1 | -$75.9M | |
| 2 | -$57.6M | |
| 3 | -$37.4M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$30.1M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$26.6M |